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relative to the valve orifice. We thank Ritter et al. and Tacy and Cape 
for drawing this issue to our attention. The beam width of the 
continuous wave Doppler transducer used in our study was -=8 to 
14 mm at depths between 8 and 12 cm. To the extent hat this beam 
width is less than the orifice area, it provides a potential source of 
error. It is one of a number of issues that require further attention. 
ANDREW I. MAclSAAC, MBBS, FRACP 
Division of Cardiovascular Medicine 
Stanford University School of Medicine 
Stanford, Cali]ornia 94305-5246 
IAN G. McDONALD, MD, FRACP, FRACR(HoN) 
SANDRA A. GRAHAM, MICTA 
RICHARD L. G. KIRSNER, BE, P~fD, FACPSEM 
Cardiac Investigation Unit and Department o[Medical Engineen'ng and Physics 
St. Vincent's Hospital. Fitzrov 
Victoria, Australia 
ROBERT W. GILL, BE, PHD, FACPSEM 
Ultrasonics Labomto O, 
Division of Radiophysics 
CSIRO, Chatswood 
New South Wales, Australia 
Pathogenesis of Stroke After Nonanterior 
Myocardial Infarction 
In their recent retrospective study. Bodenheimer tal. (1) found stroke 
to be as frequent after nonanterior myocardial infarction as after 
anterior myocardial infarction, during a follow-up period of up to 52 
months. Bodenheimer et al. quote our study finding (2) of a similar 
incidence of stroke in anterior and nonanterior myocardial infarction, 
but unlike their study our follow-up period was 1 month. The causes of 
"early" stroke in the first month after myocardial infarction (3) are 
different from those of "late" stroke after myocardial infarction (4). 
"Early" stroke has been shown in several studies (3) to be more 
frequently associated with anterior than nonanterior myocardial in- 
farction and is usually thought o be due to embolism from thrombus 
resulting from left ventricular apical akinesia. In patients with "late" 
stroke it is more difficult to identif3,' a single pathogenesis for stroke. In 
a series of 94 strokes occurring at least 3 months after myocardial 
infarction, both cardiac and noncardiac auses of stroke were identi- 
fied (4). In addition to an akinetic left ventricular segment, 21% of 
patients had significant carotid artery, disease, 12% had probable 
lacunar infarctions, and 12% had atrial fibrillation. A population-based 
study (5) found a significant difference between the observed and 
expected probability of stroke only within the first 2 months after 
myocardial infarction, suggesting that "late" stroke does not relate 
directly to myocardial infarction but to associated risk factors. If this is 
true, then the location of the myocardial infarct is not of pathogenetic 
importance for "late" strokes. 
A proportion of "early" strokes after myocardial infarction are 
associated with nonanterior myocardial infarction. In a study of 445 
patients with myocardial infarction in a population with a high 
prevalence ofdiabetes (2), we found a similar frequency of anterior (10 
[53%] of 19) and nonanterior (9 [47%] of 19) infarct location in I t) 
patients with stroke within 1 month after myocardial infarction. Three 
patients with nonanterior myocardial infarction had evidence of prob- 
able embolism. Of the nine patients with nonanterior myocardial 
infarction, seven were diabetic, five (all diabetic) bad severe hypoten- 
sion (a reduction in mean arterial pressure >25%), and in two (both 
diabetic) the onset of "early" stroke was associated with severe 
hypotension. This suggests that poor left ventricular function in 
diabetic patients may predispose to "early" stroke in nonanterior 
myocardial infarction. Global left ventricular dysfunction may thus be 
important in the pathogenesis of stroke associated with nonanterior 
myocardial infarction. Further research is needed to determine 
whether anticoagulation would reduce the risk of stroke in patients 
with nonanterior myocardial infarction who are diabetic or who have 
poor left ventricular function. 
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Reply 
Pullicino appears to agree with our essential finding, namely, that the 
similar incidence of stroke in patients with anterior and nonanterior 
myocardial infarction implies the presence of multiple mechanisms. 
That these may vary dependent on the time after infarction is entirely 
possible. Indeed, it is conceivable that myocardial infarction is an 
epiphenomenon. Thus, although Pullicino quotes Johannesen et al. (1) 
as supporting embolus as an important mechanism early in the period 
after myocardial infarction, in their study two of five patients with a 
stroke had no echocardiographic evidence of left ventricular thrombus, 
suggesting that even in this early period other causes may need to be 
considered. 
Martin et al. (2) deal only with strokes that occurred a minimum of 
3 months after a myocardial infarction. They found a multiplicity of 
potential causes, both cardiac and noncardiac, supporting our conten- 
tion that the mechanism of stroke after infarction is often not cardiac. 
Indeed, in only 14% of their patients was an akinetic left ventricular 
segment the lone risk factor that they could identify. 
In contrast to Pullicino et al. (3) we found no relation between left 
ventricular function as measured by ejection fraction and stroke (4). 
Their study "investigated the effect of diabetes on stroke after myo- 
cardial infarction" (3). Interestingly, in nondiabetic patients, they 
could not identify any risk factor for stroke (3). 
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The Standard Exercise Test Is Still the Most 
Cost-Effective 
The study by Krone et al. (1) may be misunderstood by many of the 
readers of JACC The message that they may take from it is that 
noninvasive t sting is not effective in identifying patients with coronary 
artery disease at increased risk and that invasive testing is required. 
Such a conclusion would go against a considerable body of scientific 
data as well as the guidelines published for managing patients with 
coronary disease. 
Although beautifully performed by the Multicenter Myocardial 
Infarction Research Group, this study has a tragic flaw that limits it's 
relevance to practitioners. Excluding most of the ischemic patients 
from analysis (i.e., the 21% who required bypass urgery) essentially 
negates the results. The study really does not extend our knowledge as 
to the application of the exercise test in clinical practice nor does it 
negate the "gatekeeper" ole of the standard exercise test. 
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To understand the significance of our study (1) and its findings, it is 
essential that our patient group be clearly understood. These patients 
all had evidence of corona~ artery disease and had been discharged 
after a hospital stay for either unstable angina or myocardial infarction 
in which they were evaluated for high risk, in some cases by angiog- 
raphy. Approximately 21% of patients underwent coronary bypass 
surgery, and the remaining 79% were discharged from hospital. Nearly 
one third of those discharged had undergone angioplasty as well. The 
patients were in clinically stable condition, and the exercise test was 
performed after a period of clinical stability (1 to 6 months) on 
protocol. The test was not performed to evaluate new symptoms or 
because the physician was concerned about a change in the patient's 
condition or because the patient was about o make a life-style change 
or go skiing or have a major hemodynamically stressful operation. The 
utility of stress testing in these situations has been established. 
The best analogy to this exercise test in clinical practice is the 
"yearly routine stress test" in patients in clinically stable condition. In 
this group the incidence of new events is similar to the event rate that 
we found in our patients and was not particularly low (2). We found 
that "positive" results of either the exercise test or the thallium 
perfusion scan were associated with adverse outcome, and a model 
utilizing variables related to outcomes could be constructed. However, 
the clinical utility of the exercise test and thallium perfusion scintig- 
raphy in this carefully defined, but quite large, group of patients was 
nil. This was demonstrated bythe finding that the 1-year event rate for 
new nonfatal infarctions or cardiac death for a patient with ischemia 
during thallium perfusion was 6%, whereas that for a patient with no 
ischemia was 3%. Here, the presence of ischemia identified a group 
with twice the incidence of events; but 94% of patients with ischemia 
still did not have an event, and nearly 50% of those who would develop 
events did not develop ischemia. 
It cannot be considered a "tragic flaw" of the study that the most 
seriously ischemic patients underwent coronary bypass urgery. The 
study was attempting to emulate the "real world." The study was 
addressing the problem of how to deal with the 80% of patients with 
known stable coronary disease. In these patients a routine test, 
although statistically related to events, had essentially no clinical 
utility. 
We had planned to emphasize this point by stating in the conclud- 
ing sentence of the abstract that "These results uggest a limited role 
for exercise testing in the routine follow-up of stable patients with 
known coronary disease," but the words "routine" and "stable" were 
inadvertently omitted from the final copy submitted, and perhaps their 
inclusion would have minimized any confusion. 
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